1.Staged Treatment of Pediatric IgA Vasculitis Based on the Concept of "Qi Disorder Causing Turbidity"
Hongji WU ; Ying DING ; Xuejun LI ; Qiuyan WANG ; Huifang LUO ; Jiexin SU
Journal of Traditional Chinese Medicine 2026;67(16):1784-1788
The core pathogenesis of pediatric IgA vasculitis (IgAV) is considered to involve qi movement disorder, with the failure of clear-turbid separation and internal generation of turbid pathogens. Accordingly, the viewpoint of "qi disorder causing turbidity" is proposed. In clinical practice, the disease is divided into the acute, persistent, and stable stages. The acute stage is characterized by impaired dispersion of wei (卫) qi and the internal generation of heat turbidity, while the persistent stage by congestion of ying (营) qi and retention of stasis-turbidity, and the stable stage by depletion of pectoral qi with lingering latent turbidity. In clinical practice, regulating qi and transforming turbidity is taken as the basic therapeutic principle, and the self-formulated Tiaoqi Huazhuo Decoction (调气化浊汤) is used as the basic prescription for staged treatment with flexible modifications. Specifically, the acute stage is treated with the method of dispersing wei qi and clearing heat-turbidity; the persistent stage is recommended to harmonize ying qi and purging stasis-turbidity; and the stable stage should focus on securing pectoral qi and venting latent turbidity.
2.Treatment of Pulmonary Nodules from"Cold Phlegm"
Dandan REN ; Weihong LI ; Shangbin LYU ; Zhaoliang LUO ; Jiexin WANG ; Jialiang LI ; Zhihui ZHAO
World Science and Technology-Modernization of Traditional Chinese Medicine 2023;25(10):3322-3327
The symptoms of pulmonary nodules are insidious,with inflammatory nodules,inflammatory granuloma,early invasive cancer and lung cancer,and the clinical differential diagnosis is still difficult.Regular CT follow-up observation of most pulmonary nodules provides a"window period"for TCM Intervention in pulmonary nodules.From the aspects of external cold attacking the lung,dense cold and humid geographical environment,cold diet,summer air conditioning,etc.,this paper considers that the soaking of cold pathogenic factors is the basic cause of the formation of pulmonary nodules,and cold phlegm are the basic pathogenesis of pulmonary nodules.The clinical manifestations of cold phlegm in pulmonary nodules are summarized from the two actual situations that can be distinguished from clinical symptoms and no symptoms.It is proposed that Mahuang Fuzi Xixin Decoction and Sanzi Yangqin decoction are the basic formulas,Discussion on the treatment of pulmonary nodules by warming yang and dispelling cold to cure the root cause,eliminating phlegm and softening hard mass to treat the symptoms;Improve the ability of TCM diagnosis and treatment of pulmonary nodules.
3.A novel inhibitor of N 6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities.
Guoyou XIE ; Xu-Nian WU ; Yuyi LING ; Yalan RUI ; Deyan WU ; Jiawang ZHOU ; Jiexin LI ; Shuibin LIN ; Qin PENG ; Zigang LI ; Hongsheng WANG ; Hai-Bin LUO
Acta Pharmaceutica Sinica B 2022;12(2):853-866
N 6-methyladenosine (m6A) modification is critical for mRNA splicing, nuclear export, stability and translation. Fat mass and obesity-associated protein (FTO), the first identified m6A demethylase, is critical for cancer progression. Herein, we developed small-molecule inhibitors of FTO by virtual screening, structural optimization, and bioassay. As a result, two FTO inhibitors namely 18077 and 18097 were identified, which can selectively inhibit demethylase activity of FTO. Specifically, 18097 bound to the active site of FTO and then inhibited cell cycle process and migration of cancer cells. In addition, 18097 reprogrammed the epi-transcriptome of breast cancer cells, particularly for genes related to P53 pathway. 18097 increased the abundance of m6A modification of suppressor of cytokine signaling 1 (SOCS1) mRNA, which recruited IGF2BP1 to increase mRNA stability of SOCS1 and subsequently activated the P53 signaling pathway. Further, 18097 suppressed cellular lipogenesis via downregulation of peroxisome proliferator-activated receptor gamma (PPARγ), CCAAT/enhancer-binding protein alpha (C/EBPα), and C/EBPβ. Animal studies confirmed that 18097 can significantly suppress in vivo growth and lung colonization of breast cancer cells. Collectively, we identified that FTO can work as a potential drug target and the small-molecule inhibitor 18097 can serve as a potential agent against breast cancer.
4.The clinical experience of recurred urinary stone
Mingjie YUAN ; Qiwu MI ; Ruoyu ZHANG ; Wei WANG ; Mu LI ; Jiexin LUO
Chinese Journal of Primary Medicine and Pharmacy 2006;0(03):-
Objective To summarize the clinical experience of treatment of recurred urinary stone.Methods The patients who needed to be treated again from 1998 to 2002 were reviewed.Results Patients with recurred urinary stone were differentiated by symptom,the causation of recurred stone and operation.Conclusion The pointed step must be adopted based on the clinical character of recurred urinary stone.Preventing against recurred and choosing appropriate method can improve the treatment effect.

Result Analysis
Print
Save
E-mail